Urine samples from 467 men living in the Stockholm area were fication (TMA), provides new ways to implement laboratory diagnosis, since these methods are the most sensitive ones so tested with the polymerase chain reaction (PCR), Roche Amplicor, and with an enzyme-linked immunosorbent assay, far for the detection of C. trachomatis (10) (11) (12) (13) (14) (15)(16). Gene amplification methods, as tested for in first void urine (FVU ) from Syva MicroTrak EIA, for detection of Chlamydia trachomatis. The predictive value of urine versus urethral samples was men, represent sensitive and specific screening assays that may detect all of the common urogenital C. trachomatis serovars, subsequently compared on a second urethral sample from 25 C. trachomatis-positive cases. The urethral samples were in addition even when they are present at a low titre (17-21).
. Roche Amplicor PCR versus Syva MicroTrak EIA for and C were, as a routine, investigated only by FVU. However, whenever a urine test was found to be EIA-and/or PCR-positive,
detection of C. trachomatis in urine samples
patients were also offered to attend the STD clinic in the Karolinska Hospital, where two ENT swabs were inserted 3-4 cm into the urethra MicroTrak EIA in the case of those who gave their consent and tested according to the procedures outlined above.
Amplicor PCR Positive Negative Total
Chlamydia diagnostics Positive 37 9 46 Urine samples. Fifteen to twenty millilitres of urine was collected from Negative 0 421 421 each patient and divided into two aliquots, each of which was centrifuged at 1,600 x g for 15 min. The supernatant was decanted 37a 430 467 and one of the pellets was used for Syva MicroTrakA EIA (Palo Alto, aConfirmed by direct immunofluorescence antigen. CA) and the other pellet for Roche AmplicorA PCR (HoffmanLaRoche Molecular Systems, Basel, Switzerland ).
Syva MicroTrak EIA. The urine pellet and the urethral sample were men who attended the STD clinic (group A), compared to the suspended in 1 ml specimen treatment solution. primers as well as on repeat testing by Amplicor PCR. In 2 ml urine diluent was then added and was left at room temperature addition, culture as well as PCR on urethral specimens were for 1 h. The amplification assay was performed according to the positive in 3 out of the 5 patients who had partners with instructions of the manufacturers. In the Amplicor PCR uracil-Nglucosidase is included to destroy possible amplification products from C. trachomatis infection.
previous Amplicor runs, which all incorporate dUTP instead of dTTP.
The sensitivity, specificity, positive and negative predictive
The amplified product was detected by EIA using a specific probe in values for Roche Amplicor PCR were found to be 100% in the microtitre plate.
the present study. In comparison, the sensitivity of EIA was
From the urethral culture sample (2 SP-medium) 100 ml was susonly 80% but the specificity and positive predictive value pended in 900 ml transport media diluent. The tube was kept for 1 h 100%, since only confirmed positive EIA results were included.
at room temperature, and 1 ml STD swab specimen preparation
The negative predictive value for EIA was 98%.
diluent was then added and left at room temperature for 1 h. The amplification assay was performed according to the instructions of the manufacturers.
Urethral versus urine samples and comparison between culture,
Cell culture. Isolation of C. trachomatis was performed on cyclohexi- more sensitive than EIA.
PCR and EIA

RESULTS DISCUSSION PCR versus EIA on urine samples
The high frequency of serious complications to C. trachomatis infection represents a significant threat to public health, and In Table I the results of PCR and EIA on 467 urine samples are shown. C. trachomatis were found more often in urine the potential cost-benefit aspects of implementing more efficient diagnostic methods and optimising screening programmes samples by PCR (9.9%) than by EIA (7.9%), although the difference was not statistically significant ( p=0.3007).
have been emphasised (2, 16, 20, 22, 23).
The sensitivity of the amplification assays is increased com-C. trachomatis was significantly more prevalent among the pared with non-amplification procedures like EIA and cell symptomatic patients in the age group 15-35 years. In clinical settings where screening is performed of subjectively healthy culture, and the discrepancy of the non-amplification assays is especially high for specimens with a low number of chlamydial men the sensitivity and reliability of the test are of crucial importance. particles, as is often the case in asymptomatic persons (16). This aspect is of key importance when implementing screening Sweden was the first country to establish a national laboratory service for detecting chlamydial infections. In 1988 strategies for the prevention of chlamydial infections and their sequelae (2, 16, 23).
C. trachomatis was included in legislative regulations (24) , including examination free of charge to the patients and For the PCR assay concerns have been raised about false positivity, and stringent precautions must be taken to avoid mandatory obligation of the physicians to trace contacts of infected patients. Results from multivariate logistic regression exogenous contamination (10) . In the present study this did not appear to be a problem. All those results of PCR that analysis from the county of Uppsala, north of Stockholm, on samples analysed during the period 1985-1993 (25), recently were in discordance with either EIA or culture were subsequently shown to be PCR-positive using Momp-specific demonstrated a decline in the detection rate from 107.2 per 1 000 to 32.3 in women, and from 183.3 to 70.7 in men. Positivity primers, clearly indicating that in the present study the PCR assay was 100% specific. Although no statistically significant rates were highest in STD and youth clinics and lowest in private practises. Although the chlamydial infection rate generdifferences were detected in the present study, PCR and culture yielded a higher positivity rate than EIA. By PCR 88% and ally declined, it appeared that the legislation change reduced the probability of a positive test in men but not in women. 92% of urethral and urine samples, respectively, were positive, as was 92% of swabbed urethral material that hade been Furthermore, in recent years an increase appears to have occurred in male youths and the prevalence to have levelled cultured, compared to 76% and 80% for the EIA assay when performed on urethral swab material and on FVU, off among female youths. Quite evidently, young asymptomatic males appear to represent an infectious reservoir for the respectively.
The clinical significance of using PCR for screening purposes potential maintenance of C. trachomatis at a steady-state level in the population. Accordingly, the epidemic may possibly is supported by the present study, showing that 5 of the 9 men found true positive in FVU using PCR but negative using continue to persist until highly sensitive C. trachomatis detection methods have been developed and are used routinely for EIA were partners of Chlamydia-positive female patients. This supports the concept that application of amplification assays screening.
In contrast to in women, where C. trachomatis testing is for screening outrivals immunoassays. The differences obtained in sensitivity between PCR and EIA might have been statisticcurrently implemented as part of the public health screening services in youth clinics, family planning settings and in ally significant if the study groups had been larger.
The difference in the mean ages of the population groups antenatal care units, men generally have few opportunities to be tested routinely. In men the diagnosis rather depends on in the present study, which was 28 years for the STD clinic compared to 19 and 20 years for the PYC and military their active attendance due to symptomatic illness, or due to secondary prevention measurements as part of assiduous conconscript groups, respectively, represents a marker for differences in past or current sexual behaviour. Also, while the STD tact tracing. The discomfort of urethral swabbing appears to be common knowledge that often causes refusal for screening patients self-attended due to either symptoms or a history of risk for C. trachomatis infection, the men in the two younger testing by asymptomatic young men. Accordingly, it appears obvious that if satisfactory epidemiological screening and case population groups were asymptomatic. It may be assumed that the conscripts rather represent a relatively unselected finding strategies are to be implemented, the introduction of non-invasive diagnostic methods for males is also highly group, comprising both males who have experienced their first intercourse and males who have not, while a larger proportion warranted, particularly in PYC settings. We find PCR testing on FVU ideal for this purpose. Additional gains, not the least of the PYC males are already sexually experienced. As the purpose of the present study was to investigate the usefulness when focusing on primary prevention of HIV infection, may also be made when test strategies are combined with active of PCR as a screening method on FVU, we chose to combine the PYC and military conscript groups for analysis of the information about other STDs as well, with an emphasis on targeted risk-reduction intervention and condom promotion results.
There are several reasons to screen for C. trachomatis (23) . strategies (26, 27) . First, at least half of those infected are asymptomatic carriers; screening and identifying such cases allow detection of addi-ACKNOWLEDGEMENT tional positive cases through partner notification. The latter We wish to express our sincere gratitude to Per Lundbergh, M.D., seems highly rewarding, as more than half of all partners of carriers appears to be of crucial importance for an epidemiologically oriented strategy. It has been calculated that it is cost-REFERENCES beneficial to screen for C. trachomatis when the prevalence is approximately 6%, and a prevalence of 3% has been suggested
